Search research articles
Contact Us
Filters
Showing results (181-190 of 201) with videos related to
Page
of 21
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
October 22, 2010
GH response to oral glucose tolerance test: a comparison between patients with acromegaly and other pituitary disorders
E Verrua, M Filopanti, C L Ronchi, et al.
Journal of Endocrinological Investigation
|
February 6, 2017
Long-term safety and efficacy of Omnitrope<sup>®</sup> in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study
D Ferone, E Profka, V Gasco, et al.
European Journal of Endocrinology
|
November 13, 2013
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients
C Giavoli, E Profka, E Sala, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
October 9, 2009
Evaluation of GH-IGF-I axis in adult patients with coeliac disease
E Ferrante, C Giavoli, L Elli, et al.
Journal of Endocrinological Investigation
|
March 15, 2005
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas
M Filopanti, E Ballarè, A G Lania, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 19, 2000
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide
J M Kuhn, S Arlot, H Lefebvre, et al.
Clinical Endocrinology
|
June 9, 2007
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study
C L Ronchi, M Boschetti, E C Degli Uberti, et al.
European Journal of Endocrinology
|
September 17, 2009
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function
F Ermetici, F Donadio, L Iorio, et al.
European Journal of Endocrinology
|
March 15, 2001
Two familial giant pituitary adenomas associated with overweight: clinical, morphological and genetic features
E Ferretti, M L Jaffrain Rea, C Asteria, et al.
Clinical Endocrinology
|
February 27, 2010
Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects
V Morelli, B Masserini, A S Salcuni, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 201) with videos related to
Sort By:
Page
of 21
The Journal of Clinical Endocrinology and Metabolism
|
October 22, 2010
GH response to oral glucose tolerance test: a comparison between patients with acromegaly and other pituitary disorders
E Verrua, M Filopanti, C L Ronchi, et al.
Journal of Endocrinological Investigation
|
February 6, 2017
Long-term safety and efficacy of Omnitrope<sup>®</sup> in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study
D Ferone, E Profka, V Gasco, et al.
European Journal of Endocrinology
|
November 13, 2013
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients
C Giavoli, E Profka, E Sala, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
October 9, 2009
Evaluation of GH-IGF-I axis in adult patients with coeliac disease
E Ferrante, C Giavoli, L Elli, et al.
Journal of Endocrinological Investigation
|
March 15, 2005
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas
M Filopanti, E Ballarè, A G Lania, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 19, 2000
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide
J M Kuhn, S Arlot, H Lefebvre, et al.
Clinical Endocrinology
|
June 9, 2007
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study
C L Ronchi, M Boschetti, E C Degli Uberti, et al.
European Journal of Endocrinology
|
September 17, 2009
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function
F Ermetici, F Donadio, L Iorio, et al.
European Journal of Endocrinology
|
March 15, 2001
Two familial giant pituitary adenomas associated with overweight: clinical, morphological and genetic features
E Ferretti, M L Jaffrain Rea, C Asteria, et al.
Clinical Endocrinology
|
February 27, 2010
Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects
V Morelli, B Masserini, A S Salcuni, et al.
Page
of 21